Ezara Gutierrez, DO
Adult Medicine · San Antonio, TXNPI 1942738240
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 59 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Lilly USA, LLC at 44.8% of the total. Reporting peaked in 2023 at $472 and has fallen 61.7% since, to $181 in 2025.
Across 59 payments — averaging $19.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$512
- Galderma Laboratories, L.p.$187
- AbbVie$134
- Novo Nordisk$111
- Acella Pharmaceuticals, LLC$38
- IBSA Pharma Inc.$23
- plus $139 from 9 others
What the payments were for
- Food & beverage$1,144100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 29 | $512 |
| Galderma Laboratories, L.p. | 2 | $187 |
| AbbVie | 9 | $134 |
| Novo Nordisk | 7 | $111 |
| Acella Pharmaceuticals, LLC | 2 | $38 |
| IBSA Pharma Inc. | 1 | $23 |
| Endo Pharmaceuticals Inc. | 1 | $21 |
| Pfizer | 1 | $18 |
| Halozyme Inc | 1 | $17 |
| Acerus Pharmaceuticals Corporation | 1 | $17 |
| GSK | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Amgen | 1 | $12 |
| Therapeuticsmd, Inc. | 1 | $12 |
| Boehringer Ingelheim | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MOUNJARO$125
How this compares
$1,144 in reported general payments places this provider in the 65th percentile of 98 adult medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 26 | $1,097 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 12 | $208 |
| Levothyroxine Sodium | 25 | $187 |
| Montelukast Sodium | 12 | $174 |
| Metoprolol Succinate | 12 | $44 |
| Anastrozole | 11 | $42 |
| Atorvastatin Calcium | 13 | $40 |
| Ketorolac Tromethamine | 12 | $9 |
Paid to pharmacies, not to this prescriber.
Other adult medicine in San Antonio
- Charles ClementsSan Antonio$2K
- Rachel SpencerSan Antonio$567
- Ariana Ruiz SanchezSan Antonio$485
- Deborah HornBellaire$723K
- Thomas MartensPflugerville$87K
- Sakuntalai SrinanthakumarBeaumont$48K
- Francisco Vera AdamesSpring$11K
- Latisha RoweHouston$11K
- Hong XiaoCarrollton$10K
- Mark NovasSheppard Afb$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.